|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for loan losses | |||||
| Depreciation | |||||
| Amortization of investment premiums and discounts, net | |||||
| OTTI recovery on available for sale securities | |||||
| Expense for deferred income taxes | |||||
| Stock compensation expense | |||||
| Income from bank owned life insurance | |||||
| Gain on sale of securities available for sale | |||||
| Gain on sale of mortgage loans | |||||
| Loss (gain) on disposal of premises and equipment | |||||
| Proceeds from sale of mortgage loans | |||||
| Gain on sale of foreclosed assets | |||||
| Originations of mortgage loans sold | |||||
| (Increase) decrease in: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| (Decrease) increase in accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sales, calls and maturities of securities available for sale | |||||
| Purchase of securities available for sale | |||||
| Net increase in loans | |||||
| Proceeds from sale of foreclosed assets | |||||
| Proceeds from death benefit of bank owned life insurance policy | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchase of premises and equipment | |||||
| Net increase (decrease) in deposits | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (decrease) increase in deposits | |||||
| Increase in advance payments by borrowers for taxes and insurance | |||||
| Advances from Federal Home Loan Bank | |||||
| Repayment of advances from Federal Home Loan Bank | |||||
| Increase (decrease) in repurchase agreements | |||||
| Acquisition of treasury stock | |||||
| Proceeds from repayment of ESOP loan | |||||
| Dividends paid on common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid (refund) | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Loans charged off | |||||
| Foreclosures and in-substance foreclosures of loans during year | |||||
| Net unrealized losses on investment securities classified as available for sale | |||||
| Increase in deferred tax asset related to unrealized gains on investments | |||||
| Dividends declared and payable | |||||
| Issue of unearned restricted stock | |||||
Loading...
